Helicobacter pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Control group: Patients receiving the standard 14-day Helicobacter pylori eradication regimen. Intervention 2: Intervention group: Patients receiving 14 days high-dose PPI and amoxici
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria was ages between 18 and 80 years who have H. pylori positive and have endoscopic findings of gastric ulcer or erosion, duodenal ulcer or duodenitis and or histologic evidence of intestinal metaplasia.
Exclusion criteria
Exclusion criteria: Pregnant or nursing women, those with a history of upper GI surgery, major cardiac, lung, liver or renal diseases, a history of previous H. pylori eradication regimen and history of known side effects to the protocol drugs would be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection. Timepoint: In the beginning of the study when patient enrolled the study. Method of measurement: Evaluation of Helicobacter pylori infection by RUT test or pathology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: Six to 8 weeks after end of HP eradication treatment. Method of measurement: H pylori stool antigen test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Mohammad Valizadeh Toosi
Mazandaran University of Medical Sciences
Outcome results
None listed